This HTML5 document contains 153 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q46793947
rdf:type
wikibase:Item
schema:description
artigo científico научна статия 2005年學術文章 artigo científico 2005 nî lūn-bûn 2005年学术文章 vedecký článok artykuł naukowy tudományos cikk artikull shkencor অক্টোবর ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2005年學術文章 bilimsel makale scienca artikolo 2005年学术文章 2005年學術文章 scientific article published in October 2005 სამეცნიერო სტატია artigo científico articolo scientifico wissenschaftlicher Artikel научная статья wetenschappelijk artikel 2005年学术文章 vetenskaplig artikel videnskabelig artikel artikel ilmiah teaduslik artikkel מאמר מדעי наукова стаття, опублікована в жовтні 2005 บทความทางวิทยาศาสตร์ vitenskapelig artikkel 2005年学术文章 artikulong pang-agham naučni članak مقالة علمية نشرت في أكتوبر 2005 bài báo khoa học научни чланак scientific article published in October 2005 2005년 논문 мақолаи илмӣ tieteellinen artikkeli 2005年學術文章 2005年学术文章 artículo científico publicado en 2005 2005年の論文 article scientifique article científic научни чланак scientific article published in October 2005 vitskapeleg artikkel article scientific articol științific 2005年学术文章 2005年學術文章 artículu científicu επιστημονικό άρθρο vědecký článek
p:P577
wds:Q46793947-9F752924-3B80-42CD-B0EF-D08F4E89DA8F
wdt:P577
2005-10-01T00:00:00Z
p:P2860
wds:Q46793947-164660D3-B568-4AB3-BCEF-E212D962FA3A wds:Q46793947-193555AD-5B9B-43F6-A5F2-D8F75E80322D wds:Q46793947-076DB0E3-F092-4BB0-BF13-DB3A9696024C wds:Q46793947-A7493F5F-A70A-49D4-A453-6BEDD87D212E wds:Q46793947-B90DAA15-4BA0-4A39-B9C5-E841C48B7E2C wds:Q46793947-A0DB6924-3742-4259-A584-E449C2366120 wds:Q46793947-5D6B4282-4E73-4787-BE30-891DA5B136B2 wds:Q46793947-5E28E29E-2AF2-4E24-8096-DD775CFDD850 wds:Q46793947-6A7E44E2-6564-4008-A3C4-7AFA2CA7C80D wds:Q46793947-3C368CF6-CC8D-4312-8A14-AB80A7846481 wds:Q46793947-48A41C15-ECA2-4AFD-9E44-9554942E9A07 wds:Q46793947-5510E2D2-521F-4BAD-A552-F4B355825C34 wds:Q46793947-F6F5046B-AA19-4E2E-A14D-C77503146ED1 wds:Q46793947-F2F62A77-A189-4828-86A6-2BC77493B96D wds:Q46793947-F44EBBAE-8A2C-427C-B7A0-B9101CE8B679 wds:Q46793947-DCCCD10D-2691-468F-B530-020458A1E1B8 wds:Q46793947-B97F40AA-1B37-4350-9B25-A4EF6B1015F1 wds:Q46793947-CCB2A3F8-3F7F-47BE-88DF-165804006F4B
wdt:P2860
wd:Q28139738 wd:Q43595378 wd:Q51407802 wd:Q28300531 wd:Q49013113 wd:Q33156679 wd:Q28265902 wd:Q73783799 wd:Q34171444 wd:Q40865508 wd:Q28145423 wd:Q33174548 wd:Q61850490 wd:Q74097198 wd:Q42616350 wd:Q40859876 wd:Q24291252 wd:Q24294267
p:P2093
wds:Q46793947-FB409E6D-9CF2-4A0A-A7DD-71AB230E29C0 wds:Q46793947-E03EB8D0-836C-405B-AC73-642A88A27CB7 wds:Q46793947-AD1029A2-FCD5-4C41-A238-C2169AE6DB31 wds:Q46793947-A7C77819-46D6-415D-8327-BE39280FF6B2 wds:Q46793947-1552AC50-B804-4E07-BE4A-CB341BAE8BF7 wds:Q46793947-291AAED3-4BAD-4838-910F-1C298143B4D3 wds:Q46793947-1BDABE30-B55C-497E-B89F-45397C9AF35E
wdt:P2093
Michael Cieciorka Jennifer L Robinson Scott McNitt Ming Qi James P Daubert Allan S Manalan John R Windle
rdfs:label
Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.
skos:prefLabel
Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.
schema:name
Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.
p:P50
wds:Q46793947-665B9F2B-6AC0-4F6B-BB05-BCC69BA2FE68 wds:Q46793947-83E483CF-B508-45EF-BF07-AEFB0BF5C4E9 wds:Q46793947-075BDDD8-88CD-4247-A315-356BBAA4EB95 wds:Q46793947-1A33E2A8-6E23-4AAE-829A-F04BD5742081 wds:Q46793947-C2A129E3-6B6F-44CC-8C20-1DB7147834B7 wds:Q46793947-CE1E08A5-05A7-4AD9-BC8F-703E9AB38DD7 wds:Q46793947-F6571C1E-1230-47C1-BDC8-10811676C48E
wdt:P50
wd:Q87446628 wd:Q63962680 wd:Q117194799 wd:Q117194797 wd:Q49030014 wd:Q63963026 wd:Q64680429
p:P1476
wds:Q46793947-E9541BDD-F3F9-4108-A22F-933C462C5F24
wdt:P1476
Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial
p:P304
wds:Q46793947-079E0ACE-B928-4DDF-A5D5-5157B6077312
wdt:P304
59-66
p:P31
wds:Q46793947-1C286367-BE56-4B86-BD39-E4983F39686B
wdt:P31
wd:Q13442814
p:P921
wds:Q46793947-5CA3BF59-8987-4628-AC7C-12F452A3B827
wdt:P921
wd:Q269829
p:P698
wds:Q46793947-F31E1EC0-B257-4EE3-9622-74DD17FE0957
wdtn:P698
n11:16274417
wdt:P698
16274417
p:P1433
wds:Q46793947-DA5CF520-D7BE-4FB2-B8A2-5DE2C5DAF619
wdt:P1433
wd:Q2354750
p:P433
wds:Q46793947-0C45802D-6496-4ECA-A3FC-EC00FAB5B02B
p:P478
wds:Q46793947-E85F7FE9-0BD3-4029-9303-CF613E79E05D
wdt:P433
4 Suppl
wdt:P478
10
p:P356
wds:Q46793947-1895D6EB-787E-4254-B035-1D8060B267AE
wdtn:P356
n6:J.1542-474X.2005.00077.X
wdt:P356
10.1111/J.1542-474X.2005.00077.X
p:P932
wds:Q46793947-76CBD968-3B0D-4A87-B586-4DA78106D3A2
wdt:P932
6932190